See more : CPI Computer Peripherals International (CPI.AT) Income Statement Analysis – Financial Results
Complete financial analysis of Quick Heal Technologies Limited (QUICKHEAL.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Quick Heal Technologies Limited, a leading company in the Software – Application industry within the Technology sector.
- Colas SA (RE.PA) Income Statement Analysis – Financial Results
- Sycamore Entertainment Group, Inc. (SEGI) Income Statement Analysis – Financial Results
- MetaEdge Corporation (6816.TWO) Income Statement Analysis – Financial Results
- Canada Jetlines Operations Ltd (CAJTF) Income Statement Analysis – Financial Results
- Dnake (Xiamen) Intelligent Technology Co., Ltd. (300884.SZ) Income Statement Analysis – Financial Results
Quick Heal Technologies Limited (QUICKHEAL.NS)
About Quick Heal Technologies Limited
Quick Heal Technologies Limited provides security software products and solutions to consumers, small businesses, government establishments, and corporate houses in India and internationally. The company operates through Retail, Enterprise and Government, and Mobile segments. Its products portfolio includes GoDeep.AI, a malware hunting engine; Seqrite Hawk, a cybersecurity solution; and Hawk Eye, a cloud-based platform for enterprise grade centralized security management. The company also offers technical and after-sales support services. It sells its products through a network of service providers, system integrators, resellers, and distributors. The company offers its products under Seqrite brand. Quick Heal Technologies Limited was incorporated in 1995 and is based in Pune, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.92B | 2.78B | 3.42B | 3.33B | 2.86B | 3.15B | 3.18B | 3.00B | 3.38B | 2.86B | 2.43B | 2.05B |
| Cost of Revenue | 1.75B | 93.30M | 1.50B | 191.08M | 182.87M | 225.55M | 270.48M | 373.97M | 429.51M | 403.27M | 201.93M | 149.42M |
| Gross Profit | 1.17B | 2.69B | 1.92B | 3.14B | 2.68B | 2.92B | 2.91B | 2.63B | 2.95B | 2.46B | 2.23B | 1.90B |
| Gross Profit Ratio | 40.00% | 96.64% | 56.18% | 94.26% | 93.61% | 92.84% | 91.50% | 87.53% | 87.30% | 85.91% | 91.68% | 92.71% |
| Research & Development | 0.00 | 1.21B | 897.50M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 205.30M | 271.40M | 156.10M | 101.43M | 106.60M | 67.80M | 83.75M | 148.03M | 83.59M | 31.08M | 178.54M | 98.77M |
| Selling & Marketing | 187.50M | 347.80M | 282.40M | 233.13M | 319.89M | 303.52M | 307.86M | 215.82M | 691.74M | 654.45M | 487.22M | 383.49M |
| SG&A | 398.30M | 619.20M | 438.50M | 334.56M | 426.49M | 371.32M | 391.61M | 363.85M | 775.32M | 685.53M | 1.16B | 814.66M |
| Other Expenses | 768.80M | 221.30M | 35.50M | 49.82M | 65.60M | 28.86M | 85.33M | 17.33M | 10.04M | 510.52K | 0.00 | 0.00 |
| Operating Expenses | 1.17B | 2.83B | 1.02B | 1.88B | 1.98B | 1.88B | 1.97B | 2.03B | 2.16B | 1.74B | 1.45B | 876.18M |
| Cost & Expenses | 2.83B | 2.92B | 2.52B | 2.07B | 2.16B | 2.10B | 2.25B | 2.40B | 2.59B | 2.14B | 1.65B | 1.03B |
| Interest Income | 12.90M | 17.80M | 29.00M | 71.27M | 81.29M | 110.05M | 101.28M | 185.38M | 15.62M | 3.79M | 79.95M | 80.27M |
| Interest Expense | 1.30M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 110.90M | 147.50M | 170.80M | 194.87M | 216.77M | 235.49M | 269.27M | 309.44M | 237.11M | 202.00M | 108.15M | 44.39M |
| EBITDA | 373.00M | 227.70M | 1.26B | 1.66B | 916.42M | 1.28B | 1.21B | 906.85M | 1.02B | 924.28M | 1.05B | 1.15B |
| EBITDA Ratio | 12.78% | 0.68% | 27.87% | 41.00% | 28.61% | 39.66% | 37.81% | 30.87% | 29.86% | 31.91% | 43.10% | 51.60% |
| Operating Income | 54.20M | -98.20M | 904.20M | 1.22B | 698.24M | 1.05B | 938.06M | 597.41M | 789.66M | 722.28M | 938.41M | 1.01B |
| Operating Income Ratio | 1.86% | -3.53% | 26.45% | 36.67% | 24.40% | 33.27% | 29.47% | 19.92% | 23.36% | 25.24% | 38.64% | 49.43% |
| Total Other Income/Expenses | 207.90M | -672.70M | -494.00M | -297.13M | -376.01M | -321.33M | -439.89M | -711.10M | -714.56M | -790.42M | -77.00M | 91.28M |
| Income Before Tax | 262.10M | 80.20M | 1.09B | 1.46B | 1.01B | 1.37B | 1.23B | 838.71M | 885.57M | 798.26M | 860.28M | 1.10B |
| Income Before Tax Ratio | 8.98% | 2.88% | 31.79% | 43.88% | 35.41% | 43.51% | 38.77% | 27.96% | 26.19% | 27.90% | 35.43% | 53.89% |
| Income Tax Expense | 19.70M | 16.20M | 254.90M | 391.57M | 269.00M | 451.95M | 404.11M | 306.44M | 301.57M | 260.21M | 276.46M | 335.73M |
| Net Income | 242.40M | 64.00M | 831.90M | 1.07B | 744.11M | 918.24M | 830.05M | 532.27M | 584.00M | 538.04M | 583.82M | 768.99M |
| Net Income Ratio | 8.31% | 2.30% | 24.33% | 32.12% | 26.01% | 29.16% | 26.08% | 17.74% | 17.27% | 18.81% | 24.04% | 37.51% |
| EPS | 4.56 | 1.14 | 14.01 | 16.66 | 11.34 | 13.03 | 11.82 | 7.60 | 9.29 | 8.81 | 9.43 | 12.59 |
| EPS Diluted | 4.48 | 1.14 | 13.94 | 16.65 | 11.34 | 13.02 | 11.79 | 7.55 | 9.27 | 8.69 | 9.43 | 12.59 |
| Weighted Avg Shares Out | 53.20M | 55.93M | 59.38M | 64.20M | 65.59M | 70.50M | 70.23M | 70.05M | 62.35M | 61.07M | 61.91M | 61.08M |
| Weighted Avg Shares Out (Dil) | 54.05M | 56.09M | 59.70M | 64.26M | 65.61M | 70.54M | 70.40M | 70.47M | 62.48M | 61.94M | 61.91M | 61.07M |
Source: https://incomestatements.info
Category: Stock Reports